Nick Olsen

Nick Olsen is a Principal at Innovation Endeavors since January 2021, focusing on investments at the intersection of technology, life sciences, and healthcare. Prior experience includes roles at Exsilio Therapeutics as Senior Associate and Associate, and serving on the Board of Directors for both GRO Biosciences and Tempus Labs, Inc., where Olsen contributed to strategy and operations aimed at advancing precision medicine through artificial intelligence. Previous positions include a Senior Associate Consultant and Associate Consultant at Bain & Company, and a brief stint in the Global Commercial team at Spark Therapeutics, Inc. Nick Olsen holds a Bachelor of Science in Bioengineering with a Business Minor from the University of Illinois at Urbana-Champaign.